Aclarion, Inc.
ACONHealthcareNASDAQHealth Information Services · Last scanned Oct 26, 2026
Scan Results
Daily timeframeAclarion, Inc. operates as a healthcare technology company in the United States. At a $5.6M market cap, Aclarion, Inc. ranks as a micro-cap company within healthcare. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments.
Market Cap
$5.6M
Beta
1.21
P/E (TTM)
—
P/E (Fwd)
-0.35
EPS (TTM)
$-7.38
EPS (Fwd)
$-5.47
ROE
-59.0%
ROA
-37.0%
Cash
$16.3M
Total Debt
$0
Free CF
-$5.3M
52W Change
-74.8%
Annual Financials
Cash vs Debt
Where ACON stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, ACON finished 33.68% below its 150-day moving average ($2.85) and 37.00% below its 200-day moving average ($3.00). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ACON overbought or oversold?
At the October 20, 2026 close, ACON's RSI(14) was 22.7, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Aclarion, Inc. reports $16.3M in cash and $0 in total debt. Free cash flow is running at -$5.3M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -59.0%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $60K (2022) to $76K (2025), reflecting a 25% increase over the period.
Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. No single metric tells the full story. Reviewing ACON's risk profile alongside its fundamentals and technical indicators provides a more complete picture.